PART1 and prostate carcinoma: The opposite regulation of AR signaling by these two lncRNAs also affected cell senescence, with ADAMTS9-AS2 promoting Sal-induced senescence and PART1 inhibiting Sal-induced senescence in prostate cancer cells.